Inhaled salbutamol and doping control: Effects of dose on urine concentrations

Clinical Journal of Sport Medicine

Volumn 18, Issue 3, 2008, Pages 282-285

  Sporer, Benjamin C ^a,b,c   Sheel, Andrew W ^a   Taunton, Jack ^a,b   Rupert, Jim L ^a   McKenzie, Donald C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CANADIAN SPORT INSTITUTE PACIFIC   (Canada)

Author keywords

Doping control; Salbutamol; Urine concentration

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPING; DOSE RESPONSE; DRUG CONTROL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG URINE LEVEL; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; URINALYSIS;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; BRITISH COLUMBIA; BRONCHODILATOR AGENTS; DOPING IN SPORTS; HUMANS; MALE;

EID: 43449120984     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e3181705c8c     Document Type: Article

References (12)

1. Evans ME, Walker SR, Brittain RT, et al. The metabolism of salbutamol in man. Xenobiotica. 1973;3:113-120.
2. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol. 1992;34:311-315.
3. Hindle M, Peers EM, Parry-Billings M, et al. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler. Br J Clin Pharmacol. 1997;43:336-338.
4. Tomlinson HS, Corlett SA, Chrystyn H. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation. Br J Clin Pharmacol. 2003;56:225-227.
5. Pichon A, Venisse N, Krupka E, et al. Urinary and blood concentrations of β2-agonists in trained subjects: comparison between routes of use. Int J Sports Med. 2006;27:187-192.
6. American Thoracic Society. Standardization of spirometry - 1994 update. Am J Respir Crit Care Med. 1995;152:1107-1136.
7. WADA. The World Anti-Doping Code: The 2006 Prohibited List: International Standard. Available at: http://www.wada-ama.org/rtecontent/document/2006_LIST. pdf. Accessed May 15; 2006.
8. Miller RC, Brindle E, Holman DJ, et al. Comparison of specific gravity and creatinine for normalizing urniary reproductive hormone concentrations. Clin Chem. 2004;50:924-932.
9. Ventura R, Segura J, Berges R, et al. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther Drug Monit. 2000;22:277-282.
10. McKenzie DC. Salbutamol and the competitive athlete. Clin J Sport Med. 2004;14:316.
11. Schweizer C, Saugy M, Kamber M. Doping test reveals high concentrations of salbutamol in a swiss track and field athlete. Clin J Sport Med. 2004;14:312-315.
12. Sporer BC, Sheel AW, McKenzie DC. Dose response of inhaled salbutamol on exercise performance and urine concentrations. Med Sci Sports Exerc. 2008;40:149-157.